Intrathecal baclofen for spasticity of spinal origin or due to multiple sclerosis
Record ID 32006000935
English
Authors' objectives:
Intrathecal administration of baclofen is used to relieve spasticity of spinal origin or secondary to multiple sclerosis that cannot be adequately treated with oral medications. If a screening trial involving a bolus dose of intrathecal baclofen indicates adequate response, an infusion pump is implanted to allow continuous intrathecal infusion of the drug.
Authors' methods:
Review
Details
Project Status:
Completed
Year Published:
2005
URL for published report:
http://www.hayesinc.com/hayes/crd/?crd=3663
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Injections, Spinal
- Baclofen
- Multiple Sclerosis
- Muscle Spasticity
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
HAYES, Inc.
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.